Harvard Startup Stories: Tyler Brown, i2O Therapeutics
October 14th, 2021 ~ 04:00pm - 05:00pm
Zoom; please register for details
Join us for a chat with Tyler Brown, PhD '19, and bioengineering professor Samir Mitragotri as they share the founding story of i2O Therapeutics.
Hop on Zoom for this afternoon talk featuring the scientific founders of i2O Therapeutics, a startup commercializing innovations developed at Harvard.
Hosted by Harvard Office of Technology Development.
i2O Therapeutics was launched to develop safe and effective oral formulations for a range of biologics, large molecules, and peptide-based pharmaceuticals, with an initial focus on developing formulations for GLP1 analogs, glucagon-like peptides that help balance glucose levels to treat diabetes. The foundational technology – based on ionic liquids – was developed in the Mitragotri Lab with support from Harvard's Blavatnik Biomedical Accelerator.
Tyler Brown, PhD '19, Co-Founder, Principal Scientist, and Associate Director of Technology Development at i2O Therapeutics
Samir Mitragotri, PhD, Hiller Professor of Bioengineering and Hansjorg Wyss Professor of Biologically Inspired Engineering at Harvard John A. Paulson School of Engineering and Applied Sciences; Core Faculty member at Harvard's Wyss Institute for Biologically Inspired Engineering